Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Ocriplasmin

Brand: JETREA®
NICE TA: 297
Indication: Vitreomacular traction (NICE TA297)
Disease category: Eye
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Ocriplasmin is recommended as a possible treatment for adults with an eye condition called vitreomacular traction who also have:
•no epi-retinal membrane (a thin layer of scar tissue over their retina, the light-sensitive area at the back of the eye) and
•a hole (up to 400 micrometers) in the centre of their retina or
•severe sight problems.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA297 - Ocriplasmin for treating vitreomacular traction 

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red